I
Interrad Medical
Interrad Medical develops innovative medical devices for use in minimally invasive interventional and surgical procedures
About Interrad Medical
SecurAcath specializes in developing and providing an innovative catheter securement device designed to reduce catheter-related infections and dislodgements. Operating in the healthcare market, SecurAcath serves hospitals, clinics, and healthcare providers who require reliable and cost-effective catheter securement solutions. The company's business model revolves around the sale of its patented SecurAcath device, which is recommended by the National Institute for Health and Care Excellence (NICE) and supported by extensive clinical evidence. SecurAcath generates revenue through direct sales to healthcare institutions and through partnerships with medical device distributors. The device offers significant cost savings by lowering the total cost of patient care through reduced complications and improved patient outcomes.
Source: Dealroom company dataAt a glance
- Founded
- 2000
- Headquarters
- Plymouth, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Arthurian Life Sciences
RBC Dominion Securities
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Interrad Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Interrad Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.